Singapore markets open in 4 hours 41 minutes
Straits Times Index
3,330.09 +11.64 (+0.35%) S&P 500
5,306.04 +1.32 (+0.02%) Dow
38,852.86 -216.73 (-0.55%) Nasdaq
17,019.88 +99.09 (+0.59%) Bitcoin USD
68,411.38 -1,062.48 (-1.53%) CMC Crypto 200
1,481.85 -14.61 (-0.98%)
MRK Jun 2025 105.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:17AM EDT. Market open.
| Previous close | 31.40 |
| Open | 31.40 |
| Bid | 26.25 |
| Ask | 27.95 |
| Strike | 105.00 |
| Expiry date | 2025-06-20 |
| Day's range | 31.40 - 31.40 |
| Contract range | N/A |
| Volume | |
| Open interest | 768 |
Business WireMerck Announces Third-Quarter 2024 Dividend
RAHWAY, N.J., May 28, 2024--Merck Announces Third-Quarter 2024 Dividend
BenzingaMerck's Multi-Billion Cancer Drug Keytruda Aces Late-Stage Breast Cancer Study (UPDATED)
Editor’s Note: The title of the story is updated to correct the reference to ‘Breast’ cancer instead of ‘Lung’ cancer. Tuesday, Merck & Co Inc (NYSE:MRK) released topline data from hase 3 KEYNOTE-522 trial of Keytruda in high-risk early-stage triple-negative breast cancer (TNBC). The study evaluated Keytruda in combination with chemotherapy as a pre-operative (neoadjuvant) treatment and then continuing as a single agent after surgery (adjuvant). The study met its overall survival (OS) endpoint.
Simply Wall St.Is Merck & Co., Inc.'s (NYSE:MRK) Recent Performance Underpinned By Weak Financials?
Merck (NYSE:MRK) has had a rough month with its share price down 1.3%. To decide if this trend could continue, we...
© 2024 Yahoo. All rights reserved.